Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of drug resistant cancer cells

Inhibition of drug resistant cancer cells

US Patent 9101579 · Granted Aug 11, 2015

Estimated economic value: $198,308,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other c2025
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopi2023
Antiproliferative compounds and methods of use thereof2022
Methods for determining drug efficacy for the treatment of diffuse large B-cell 2021
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas2021
Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas2020
Combination therapy for treating malignancies2020
Combination therapy for treating malignancies2020
Combination therapy for treating malignancies2020
Combination therapy for treating malignancies2020
Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas2020
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas2020